DXY Group Joins Forces with Global Pharma Partners at CIIE to Champion Digital Transformation in Healthcare

On November 6, Li Tiantian, founder and chairman of DXY, was invited to attend the special launch event for Novartis’s “365 Questions About Psoriasis” at the China International Import Expo (CIIE), where he participated in a roundtable discussion and the launch ceremony.

Swipe to view on-site photos

“365 Questions on Psoriasis,” supported by Novartis China and the China Primary Health Care Foundation, with professional support from DXY, co-created by 109 physicians across China, and published by People’s Medical Publishing House, aims to serve as an essential reference for every patient with psoriasis, enabling the general public to understand the disease, approach it scientifically, and benefit a broader patient population.

On November 6, Li Tiantian, Founder and Chairman of DXY, toured the exhibition alongside Simon Holland, Head of Organon’s Global Women’s Health Contraception Business. They engaged in an insightful dialogue on health challenges facing women in modern society and how innovative technologies can safeguard female fertility and overall health.

In addition, Cong Lulu, Vice President of DXY, was also invited to participate in the roundtable discussion at the Organon booth, exploring topics related to women's health protection and fertility.

Through the collaboration between Organon and DXY, we look forward to jointly ushering in a new era of precise, comprehensive, efficient, and innovative women’s health management, progressing from “establishing scientific awareness” to “providing integrated health solutions for women’s health and fertility preservation.”

On November 6, at MSD’s “Shining for the Future, Sharing Health” booth event, Luo Gang, Vice President of Government Affairs at DXY, attended a roundtable discussion as a representative of DXY. The discussion focused on leveraging digital solutions to advance the goals of “Healthy China 2030.” Drawing on DXY’s exploratory practices in supporting Healthy China 2030, he shared insights on how the industry can utilize digital technologies to promote standardization and homogenization of diagnosis and treatment, thereby benefiting more patients.

Swipe to view on-site photos

On November 7, Abbott Medical Nutrition, in partnership with DXY, officially released the answer booklet “Twelve Key Questions on Nutrition for Stroke Patients” at the China International Import Expo (CIIE). Cong Lulu, Vice President of DXY, was invited to participate in the launch event and engaged in in-depth discussions with experts on topics such as stroke and nutrition science popularization during the roundtable discussion session.

Swipe to view on-site photos

“Twelve Questions on Nutrition for Stroke Patients” Answer Book is an educational tool that balances authority, practicality, and interactivity. It aims to save physicians’ time in patient education and provide professional support to stroke patients and their families. Presented in a question-and-answer format, it covers multiple aspects including screening, assessment, treatment, and home-based management of post-stroke malnutrition. Through this answer book, we hope to help more stroke patients and their families understand the importance of nutrition, thereby facilitating better collaboration with physicians in nutritional management.

On November 8, Bayer and DXY jointly pre-released the “Answer Book on Bone Metastasis in Prostate Cancer” at the China International Import Expo (CIIE). Helen Zhou Yongxia, Head of the Oncology Business Unit at DXY, attended the launch event as a representative of DXY and delivered the opening remarks, addressing the compilation process, content coverage, and significance of the publication.

Swipe to view on-site photos

“The Answer Book on Bone Metastasis in Prostate Cancer” is a comprehensive popular science handbook compiled to address the medical field of bone metastasis in prostate cancer, a highly prevalent condition that severely impacts patients’ health and quality of life. It aims to fill knowledge gaps, dispel rumors and misconceptions, and provide patients with authoritative, accurate, and practical scientific information. The compilation process focused on patient needs, extensively collecting and integrating the top ten questions of greatest concern to patients with bone metastasis from prostate cancer. Dozens of leading experts in prostate cancer across China were invited to provide detailed answers and conduct rigorous reviews, ensuring the scientific validity, authority, and practicality of the content.